4CPS-057 Dalbavancina and tedizolid: adequate alternatives for strains with reduced sensitivity to vancomycin, daptomycin or linezolid?

BACKGROUND: We ask if dalvabancina and tedizolid are good alternatives for strains with reduced sensitivity to vancomycin, daptomycin or linezolid. PURPOSE: To determine the most cost-effective treatment option for GRAM +microorganisms with reduced sensitivity to vancomycin, linezolid or daptomycin,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Hosp Pharm
Main Authors: Navarro, M, Betancor, T, Tévar, E, Calzado, G, Suárez, M, Plasencia, I, Ramos, E, Gómez, E, Ferrer, A, Vera, M, Merino, J
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 4: Clinical pharmacy services
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535377/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.148
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki